Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL1361604

CCNCC(=O)O.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL41068 0.97
SCHEMBL28851694 0.94
Water SCHEMBL27646883 0.94
SCHEMBL27740772 0.94
SCHEMBL27981934 0.94
Hydrochloric Acid SCHEMBL23174893 0.94
SCHEMBL31198194 0.94
Hydrochloric Acid SCHEMBL272523 0.94
SCHEMBL3882468 0.94 FFAR3 (0.43)
SCHEMBL27503883 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442788-B2 Antisense molecules and method of controlling expression of gene function by using the same JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2008-10-28 US claimed
US-6872809-B2 Nucleoside derivatives JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2005-03-29 US claimed
US-20030208050-A1 Nucleoside derivatives JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-11-06 US claimed
US-20030162739-A1 Antisense molecules and method of controlling expression of gene function by using the same JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-08-28 US claimed
EP-1295892-A1 ANTISENSE MOLECULES AND METHOD OF CONTROLLING EXPRESSION OF GENE FUNCTION BY USING THE SAME Japan Science and Technology Corporation (JP) 2003-03-26 EP claimed
EP-1295891-A1 NUCLEOSIDE DERIVATIVES Japan Science and Technology Corporation (JP) 2003-03-26 EP claimed
US-12559763-B2 FAD2 genes and mutations CIBUS US LLC (US) 2026-02-24 US disclosed
EP-3772905-B1 FAD2 GENES AND MUTATIONS CIBUS US LLC (US) 2026-02-18 EP disclosed
EP-4136963-B1 METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR CIBUS US LLC (US) 2026-01-21 EP disclosed
EP-4653531-A1 ANTISENSE OLIGOMERS TARGETING GFRAL AND USE THEREOF Korea Advanced Institute of Science and Technology (KR) 2025-11-26 EP disclosed
US-12331303-B2 Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair CIBUS US LLC (US) 2025-06-17 US disclosed
US-20250066805-A1 METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR CIBUS US LLC (US) 2025-02-27 US disclosed
US-20240376473-A1 ANTISENSE COMPOUND FOR MODULATING WFDC2 EXPRESSION QMINE CO., LTD. (KR) 2024-11-14 US disclosed
EP-1295892-A1 ANTISENSE MOLECULES AND METHOD OF CONTROLLING EXPRESSION OF GENE FUNCTION BY USING THE SAME Japan Science and Technology Corporation (JP) 2003-03-26 EP disclosed
EP-1295891-A1 NUCLEOSIDE DERIVATIVES Japan Science and Technology Corporation (JP) 2003-03-26 EP disclosed
WO-2001096355-A1 NUCLEOSIDE DERIVATIVES JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2001-12-20 WO disclosed
EP-0885238-A1 SUBSTITUTED NUCLEIC ACID MIMICS NIELSEN, Peter Eigil (DK) 1998-12-23 EP disclosed
WO-1997032888-A1 SUBSTITUTED NUCLEIC ACID MIMICS ISIS PHARMACEUTICALS, INC. (US) 1997-09-12 WO disclosed
EP-0792283-A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH CHIRON CORPORATION (US) 1997-09-03 EP disclosed
WO-1996015143-A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH CHIRON CORPORATION (US) 1996-05-23 WO disclosed